Concepedia

Kiichiro Ueta

KU

Statistics

Publications

32

Citations

2.3K

H-Index

24

Active since

1997

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

The University of Tokyo

Teikoku Seiyaku (Japan)

Gunma University

The Institute of Medical Science, Asahi Life Foundation

Kiichiro Ueta is an author at Mitsubishi Tanabe Pharma Corporation specializing in pharmacology, diabetes mellitus, and medicine.

ORCID

Publications per year

1997–2021

32

Publications

32

Discovery of Canagliflozin, a Novel <i>C</i>-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Sumihiro Nomura, Shigeki Sakamaki, Mitsuya Hongu et al. · Journal of Medicinal Chemistry · 2010 · 379 citations · Full text

, , +17

T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.

Akira Oku, Kiichiro Ueta, Kenji Arakawa et al. · Diabetes · 1999 · 253 citations

, , +17

Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models

Yin Liang, Kenji Arakawa, Kiichiro Ueta et al. · PLoS ONE · 2012 · 243 citations · Full text

, , +17

Improved diabetic syndrome in C57BL/KsJ‐db/db mice by oral administration of the Na<sup>+</sup>‐glucose cotransporter inhibitor T‐1095

Kenji Arakawa, Tomomi Ishihara, Akira Oku et al. · British Journal of Pharmacology · 2001 · 161 citations · Full text

, , +17

Na<sup>+</sup>-Glucose Cotransporter (SGLT) Inhibitors as Antidiabetic Agents. 4. Synthesis and Pharmacological Properties of 4‘-Dehydroxyphlorizin Derivatives Substituted on the B Ring

Kenji Tsujihara, Mitsuya Hongu, Kunio SAITO et al. · Journal of Medicinal Chemistry · 1999 · 123 citations

, , +16

1–5 of 32